BRAF rearrangements
About
Gene context: BRAF
Biomarker Type: Rearrangement
Present: True
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | BRAF rearrangements | Low-Grade Glioma, NOS | Tovorafenib |